Australia's most trusted
source of pharma news
Wednesday, 22 January 2025
Posted 20 January 2025 PM
The US government is getting behind Vaxxas' high-density microarray patch (HD-MAP) yet again - this time to administer mRNA vaccines against Covid.
The Brisbane-based biotech and the University of Queensland's BASE facility have been announced as one of four Concept Stage winners of the Biomedical Advanced Research and Development Authority's (BARDA) US$50 million Patch Forward Prize - one of the largest incentives backed by the US Department of Health and Human Services.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.